1887

Abstract

Topical delivery of nitric oxide (NO) through a wound dressing has the potential to reduce wound infections and improve healing of acute and chronic wounds. This study characterized the antibacterial efficacy of an ointment containing NO-loaded, zinc-exchanged zeolite A that releases NO upon contact with water. The release rate of NO from the ointment was measured using a chemiluminescence detection system. Minimum bactericidal concentration assays were performed using five common wound pathogens, including Gram-negative bacteria ( and ), Gram-positive bacteria ( and meticillin-resistant ) and a fungus (). The time dependence of antimicrobial activity was characterized by performing log-reduction assays at four time points after 1–8 h ointment exposure. The cytotoxicity of the ointment after 24 h was assessed using cultured 3T3 fibroblast cells. Minimum microbicidal concentrations (MMCs) for bacterial organisms (5×10 c.f.u.) ranged from 50 to 100 mg ointment (ml media); the MMC for (5×10 c.f.u.) was 50 mg ointment (ml media). Five to eight log reductions in bacterial viability and three log reductions in fungal viability were observed after 8 h exposure to NO–zeolite ointment compared with untreated organisms. Fibroblasts remained viable after 24 h exposure to the same concentration of NO–zeolite ointment as was used in antimicrobial tests. In parallel studies, full-thickness cutaneous wounds on Zucker obese rats healed faster than wounds treated with a control ointment. These data indicate that ointment containing NO-loaded zeolites could potentially be used as a broad-spectrum antimicrobial wound-healing dressing.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.067322-0
2014-02-01
2019-10-15
Loading full text...

Full text loading...

/deliver/fulltext/jmm/63/2/203.html?itemId=/content/journal/jmm/10.1099/jmm.0.067322-0&mimeType=html&fmt=ahah

References

  1. Balin A. K., Pratt L.. ( 2002;). Dilute povidone-iodine solutions inhibit human skin fibroblast growth. . Dermatol Surg 28:, 210–214. [CrossRef][PubMed]
    [Google Scholar]
  2. Burd A., Kwok C. H., Hung S. C., Chan H. S., Gu H., Lam W. K., Huang L.. ( 2007;). A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. . Wound Repair Regen 15:, 94–104. [CrossRef][PubMed]
    [Google Scholar]
  3. Eardley W. G., Watts S. A., Clasper J. C.. ( 2012;). Limb wounding and antisepsis: iodine and chlorhexidine in the early management of extremity injury. . Int J Low Extrem Wounds 11:, 213–223. [CrossRef][PubMed]
    [Google Scholar]
  4. Fox S., Wilkinson T. S., Wheatley P. S., Xiao B., Morris R. E., Sutherland A., Simpson A. J., Barlow P. G., Butler A. R., Megson I. L.. ( 2010;). NO-loaded Zn2+-exchanged zeolite materials: a potential bifunctional anti-bacterial strategy. . Acta Biomater 6:, 1515–1521. [CrossRef][PubMed]
    [Google Scholar]
  5. Friedman A. J., Han G., Navati M. S., Chacko M., Gunther L., Alfieri A., Friedman J. M.. ( 2008;). Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. . Nitric Oxide 19:, 12–20. [CrossRef][PubMed]
    [Google Scholar]
  6. Ghaffari A., Miller C. C., McMullin B., Ghahary A.. ( 2006;). Potential application of gaseous nitric oxide as a topical antimicrobial agent. . Nitric Oxide 14:, 21–29. [CrossRef][PubMed]
    [Google Scholar]
  7. Ghaffari A., Jalili R., Ghaffari M., Miller C., Ghahary A.. ( 2007;). Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections. . Wound Repair Regen 15:, 368–377. [CrossRef][PubMed]
    [Google Scholar]
  8. Jones M. L., Ganopolsky J. G., Labbé A., Wahl C., Prakash S.. ( 2010;). Antimicrobial properties of nitric oxide and its application in antimicrobial formulations and medical devices. . Appl Microbiol Biotechnol 88:, 401–407. [CrossRef][PubMed]
    [Google Scholar]
  9. Keefer L. K.. ( 2005;). Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities. . Curr Top Med Chem 5:, 625–636. [CrossRef][PubMed]
    [Google Scholar]
  10. Kröncke K. D., Suschek C. V.. ( 2008;). Adulterated effects of nitric oxide-generating donors. . J Invest Dermatol 128:, 258–260. [CrossRef][PubMed]
    [Google Scholar]
  11. Li Y., Lee P. I.. ( 2010;). Controlled nitric oxide delivery platform based on S-nitrosothiol conjugated interpolymer complexes for diabetic wound healing. . Mol Pharm 7:, 254–266. [CrossRef][PubMed]
    [Google Scholar]
  12. Liu H. A., Balkus K. J. Jr. ( 2009;). Novel delivery system for the bioregulatory agent nitric oxide. . Chem Mater 21:, 5032–5041. [CrossRef]
    [Google Scholar]
  13. Miller C. C., Miller M. K., Ghaffari A., Kunimoto B.. ( 2004;). Treatment of chronic nonhealing leg ulceration with gaseous nitric oxide: a case study. . J Cutan Med Surg 8:, 233–238. [CrossRef][PubMed]
    [Google Scholar]
  14. Morris R. E., Wheatley P. S.. ( 2008;). Gas storage in nanoporous materials. . Angew Chem Int Ed Engl 47:, 4966–4981. [CrossRef][PubMed]
    [Google Scholar]
  15. Mowbray M., Tan X., Wheatley P. S., Rossi A. G., Morris R. E., Weller R. B.. ( 2008;). Topically applied nitric oxide induces T-lymphocyte infiltration in human skin, but minimal inflammation. . J Invest Dermatol 128:, 352–360. [CrossRef][PubMed]
    [Google Scholar]
  16. Ormerod A. D., Copeland P., Hay I., Husain A., Ewen S. W.. ( 1999;). The inflammatory and cytotoxic effects of a nitric oxide releasing cream on normal skin. . J Invest Dermatol 113:, 392–397. [CrossRef][PubMed]
    [Google Scholar]
  17. Rizk M., Witte M. B., Barbul A.. ( 2004;). Nitric oxide and wound healing. . World J Surg 28:, 301–306. [CrossRef][PubMed]
    [Google Scholar]
  18. Shin J. H., Metzger S. K., Schoenfisch M. H.. ( 2007;). Synthesis of nitric oxide-releasing silica nanoparticles. . J Am Chem Soc 129:, 4612–4619. [CrossRef][PubMed]
    [Google Scholar]
  19. Steed D. L.. ( 2003;). Wound-healing trajectories. . Surg Clin North Am 83:, 547–555, vi–vii. [CrossRef][PubMed]
    [Google Scholar]
  20. Thomas D. D., Liu X., Kantrow S. P., Lancaster J. R. Jr. ( 2001;). The biological lifetime of nitric oxide: implications for the perivascular dynamics of NO and O2. . Proc Natl Acad Sci U S A 98:, 355–360. [CrossRef][PubMed]
    [Google Scholar]
  21. Vermeulen H., Westerbos S. J., Ubbink D. T.. ( 2010;). Benefit and harm of iodine in wound care: a systematic review. . J Hosp Infect 76:, 191–199. [CrossRef][PubMed]
    [Google Scholar]
  22. Weller R., Finnen M. J.. ( 2006;). The effects of topical treatment with acidified nitrite on wound healing in normal and diabetic mice. . Nitric Oxide 15:, 395–399. [CrossRef][PubMed]
    [Google Scholar]
  23. Wheatley P. S., Butler A. R., Crane M. S., Fox S., Xiao B., Rossi A. G., Megson I. L., Morris R. E.. ( 2006;). NO-releasing zeolites and their antithrombotic properties. . J Am Chem Soc 128:, 502–509. [CrossRef][PubMed]
    [Google Scholar]
  24. Wheatley P. S., McKinlay A. C., Morris R. E.. ( 2008;). A comparison of zeolites and metal organic frameworks as storage and delivery vehicles for biologically active nitric oxide. . In Zeolites and related materials: trends, targets and challenges, Proceedings of the 4th International FEZA Conference, Paris, France, 2–6 September 2008. Edited by Gédéon A., Massiani P., Babonneau F... Stud. Surface Sci Catalysis 174, 441–446. [CrossRef][PubMed]
    [Google Scholar]
  25. Zacharia I. G., Deen W. M.. ( 2005;). Diffusivity and solubility of nitric oxide in water and saline. . Ann Biomed Eng 33:, 214–222. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.067322-0
Loading
/content/journal/jmm/10.1099/jmm.0.067322-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error